Clinical Evaluation and Assessment of Instruments and Biomarkers in Subjects With Wilson Disease
Clinical trial NCT04531189 · COMPLETED
Trial details
- NCT number
- NCT04531189
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-11
- Primary completion
- 2022-03-25
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.